|1.||Dougados, M: 5 articles (02/2008 - 10/2001)|
|2.||Dhaneshwar, Suneela: 4 articles (01/2015 - 01/2013)|
|3.||Jain, Achint: 3 articles (09/2015 - 05/2013)|
|4.||Singh, Sanjay: 3 articles (09/2015 - 05/2013)|
|5.||Patil, Dipmala: 3 articles (01/2015 - 01/2013)|
|6.||Stoltz, J F: 3 articles (01/2010 - 01/2008)|
|7.||Tamura, T: 3 articles (05/2001 - 01/2001)|
|8.||Singh, Royana: 2 articles (09/2015 - 07/2014)|
|9.||Hernandez, Arnaldo José: 2 articles (02/2015 - 10/2006)|
|10.||Singh, Sanjay Kumar: 2 articles (07/2014 - 05/2013)|
01/01/2015 - "In the osteoarthritis diacerein-treated group the results showed an improvement with respect to the OA placebo group in all parameters, although the results were not statistically significant. "
07/12/2002 - "Diacerein has proved to be effective in the treatment of osteoarthritis. "
04/01/2001 - "Diacerein has proved to be effective in the treatment of osteoarthritis (OA). "
01/01/2001 - "Diacerein has proved to be effective in the treatment of osteoarthritis. "
07/01/1993 - "Cultured rabbit joint chondrocytes were exposed to diacerhein (DAR : ART 50, Negma, 10(-6) to 10(-4) M), which has proved effective and safe when given for two months for the treatment of osteoarthritis. "
01/12/2002 - "Diacerein is a drug with prolonged antiosteoarthritis action that has proven efficacy for symptom relief equi-valent to NSAID assessed in terms of pain relief and function: the ECHODIAH study provides arguments favoring its chondromodulating effect."
01/01/2014 - "-quality evidence from six trials (1,283 participants) indicates that diacerein has a small beneficial effect on overall pain (measured on a 100 mm visual analogue scale) at three to 36 months (mean difference (MD) -8.65, 95% confidence interval (CI) -15.62 to -1.68), which is equivalent to a 9% pain reduction in the diacerein group (95% CI -16% to -2%) compared with the placebo group. "
03/01/2010 - "Six trials (seven sub-studies; 1533 patients) contributed to the meta-analysis, revealing a large degree of inconsistency among the trials (I(2)=56%) in regard to pain reduction: the combined ES was -0.24 [95% confidence intervals (CI): -0.39 to -0.08, P=0.003], favouring diacerein. "
04/01/2015 - "Diacerein leads to pain relief, with a superior carryover effect when compared with placebo. "
01/01/2014 - "We confirmed that symptomatic benefit provided by diacerein in terms of pain reduction is minimal. "
06/01/2012 - "To observe the therapeutic efficacy of Qianggu Granule (QGG), Diacerein Capsule (DC), and QGG + DC in treating knee osteoarthritis (KOA, belonging to Gan-Shen insufficiency induced vein stasis syndrome), and to explore the clinical advantages of QGG + DC. "
12/01/2007 - "To determine whether the efficacy of diacerein persists at 2 months after the end of a 3-month treatment period, compared with placebo, in patients with painful knee osteoarthritis (OA). "
06/01/2012 - "[Clinical study of Qianggu granule and diacerein capsule in treating knee osteoarthritis]."
10/01/2009 - "Sixty-four patients of knee osteoarthritis fulfilling American College of Rheumatology Criteria were randomized to receive either diacerein or placebo for 8 weeks, followed by 4 weeks "treatment-free" follow-up in this single-blind, parallel group, post-marketing trial. "
10/01/2009 - "The objective of this study was to evaluate the efficacy and safety of diacerein in early, symptomatic knee osteoarthritis in Indian population. "
|4.||Hip Osteoarthritis (Coxarthrosis)
09/25/2006 - "This systematic meta-analysis provides evidence for the symptomatic efficacy of diacerein in the treatment of knee and hip osteoarthritis, with reasonable tolerability."
12/07/2002 - "RADIOGRAPHIC FINDINGS: The ECHODIAH study conducted to evaluate the structure-modifying effect of diacerein in hip osteoarthritis. "
01/12/2002 - "The principal objective of ECHODIAH study conducted in patients with hip osteoarthritis was to evaluate the chondroprotective effect of potential of diacerein compared with placebo. "
11/01/2001 - "Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. "
01/01/2000 - "In this study, Harpagophytum was at least as effective as a reference drug (diacerhein) in the treatment of knee or hip osteoarthritis and reduced the need for analgesic and nonsteroidal anti-inflammatory therapy."
01/01/2008 - "Thus, in conclusion, the results of the present study in a large population of Indian patients indicates that diacerein constitutes a novel approach to the treatment for the short- and long-term symptomatic management in Indian patients with osteo-arthritis of the knee."
01/01/2008 - "The present study was, therefore, undertaken to evaluate the efficacy and tolerability of diacerein in the treatment of osteo-arthritis. "
02/01/2015 - "1) The experimental model produced mild arthritis after three months and severe arthritis after seven months; 2) diacerein reduced the degenerative changes in both knees; 3) HA protected the joint cartilage; 4) Combining the two drugs did not improve the results."
01/01/2008 - "Diacerein has been recently introduced in India for the treatment of osteo-arthritis. "
01/01/2008 - "An open prospective study on postmarketing evaluation of the efficacy and tolerability of diacerein in osteo-arthritis of the knee (DOK)."
|1.||Hyaluronic Acid (Hyaluronan)
|2.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Mud Therapy (Mud Bath)